FER Regulates Endosomal Recycling and Is a Predictor for Adjuvant Taxane Benefit in Breast Cancer

0
101
The authors showed that high feline sarcoma-related non-receptor tyrosine kinase (FER) levels were also associated with improved outcomes after adjuvant taxane-based combination chemotherapy in high-risk, HER2-negative patients.
[Cell Reports]

Sorry, but the selected Zotpress account can't be found.

Full Article